CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 233 enrolled
Drug / intervention
Anticoagulation Stewardship Programother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03812848
NCT03812848N/ACompleted

Implementation of Clinical Pharmacist-led Inpatient Anticoagulation Stewardship Program in An Egyptian Tertiary Care Hospital

Ain Shams University·interventional·Posted Jan 23, 2019·Updated Sep 21, 2022

In Brief

A clinical study evaluating Anticoagulation Stewardship Program for Deep Vein Thrombosis and 2 related conditions. Completed, enrolled 233 participants across 1 site.

Detailed Summary

This study aims at evaluating the implementation of clinical-pharmacist-led anticoagulation stewardship program in Egyptian tertiary hospital to promote a culture of safety around anticoagulants.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 23, 2019
Enrollment StartJan 1, 2018
Primary CompletionJun 5, 2022
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 7.4 years ago

Interventions

Anticoagulation Stewardship Programother

A clinical-pharmacist led anticoagulation stewardship program that includes: 1. Warfarin monitoring and dosing protocol. 1a.Warfarin initial dosing algorithm. 1b.Recommended International normalized ration (INR) target and duration of Warfarin therapy by indication. 1c.Warfarin dosage adjustment algorithms. 1d.Management of high INR values. 2-Heparin weight-based protocol. 3-Perioperative anticoagulation use protocol. 4-Policies that address baseline and ongoing laboratory monitoring for anticoagulants. 5-Protocol for Heparin Induced Thrombocytopenia(HIT) management. 6-Anticoagulation reversal protocol. 7-Booklet for anticoagulant drugs and all of previously prepared protocols. 8-Education programs regarding anticoagulation's therapy for health care team dealing with anticoagulation and patients.